A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE
about
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosusIdentification of an Epstein-Barr virus-coded thymidine kinase.The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genesThe Raji cell radioimmune assay for detecting immune complexes in human seraStructural variants of human T200 glycoprotein (leukocyte-common antigen)Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells.Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytesActivation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.Herpesvirus-lymphoid cell interactions: comparative studies on the biology of herpes simplex virus-induced Fc receptors in B, T, and "null" lymphoid cell linesEffect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replicationCytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein-Barr virus and human adenovirusesSpliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide.Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells.Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus.Persistent infection of a human lymphoblastoid cell line with equine herpesvirus 1Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human seraEpstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.Linear association between cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid cell lineActivation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).Apoptosis in lymphocytic leukemias and lymphomas.Comparative study of alkaline phosphatase activity in lymphocytes, mitogen-induced blasts, lymphoblastoid cell lines, acute myeloid leukemia, and chronic lymphatic leukemia cells.Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cellsInfluence of ND10 components on epigenetic determinants of early KSHV latency establishment.Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell linesEpstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.In vitro transcription of two Epstein-Barr virus specified small RNA molecules.Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication.Murine models of B-cell lymphomas: promising tools for designing cancer therapiesMultiple roles of Epstein-Barr virus SM protein in lytic replication.Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus.Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter.Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines
P2860
Q24302256-89492640-88A9-4602-9223-CAF756E881AEQ24531739-F79E9D08-AD1D-4601-A0E2-FD61380BC949Q24556502-F556CF7E-0ECB-486D-B274-8B5B935781F5Q24563492-73B157A3-94FE-4CF9-9266-5D7654401524Q28115267-34393936-5F36-4FA1-94AF-CF6BFDA8C136Q30794920-44EA4CBF-0CB6-4BD6-991C-B4AEDFBC01F3Q33576126-6713767C-6431-4C87-9AD6-2B2EE5CED39AQ33613910-3FA9F242-A5AC-4DBB-B916-41482FE5FA37Q33632309-7070F44B-9436-40EF-A2D4-DF6941E5647CQ33813615-913CDAE5-73F5-479E-9282-ED09F0EA3072Q33907657-0D54712F-9F4F-4C2D-8679-FE7298CA6A6AQ33911648-478A465F-488A-45AD-8E01-CFF11190244DQ33919850-C34C16D9-7D89-44C6-810A-C9C9FCB0B74CQ33933857-E7D6E008-8F65-42C6-BC81-747559C6AF33Q33939801-018575B0-B909-47B9-B157-36C629C62586Q33993543-B4EE3487-9659-46F1-B013-0DB24306B248Q34057890-D42F6C37-C584-4749-93C4-6A297A143F74Q34078753-2DD1491A-0F79-41AB-B9FC-24A2331EAC6CQ34084028-C5ED3D29-71EB-4AED-BCDC-33619D84ABDAQ34228526-8CA73DB4-4A68-4913-8E7E-D0C7563F32EDQ34276501-E2BFD05E-C20D-4B5D-A743-3E5695F2F4A2Q34386338-8F00C3BC-27EC-4456-B9DB-427E32ABD5FEQ34507851-EC84524F-B2C4-44DA-AAB5-C0702A005F7FQ34738558-E27802FA-D5A7-475D-B5A1-455E131577A0Q34766546-1B549266-9194-4914-ADA4-629313BCB204Q34798677-B541B6A5-A006-49E4-BB91-3DEB9A12F16DQ35000172-AD6C54A5-03CB-488C-8CB8-164A138EEF0CQ35019443-9FBCFD89-858F-4EB7-9E00-25476CFC09DFQ35076361-018413F1-3812-47B9-BE0A-3F0B9602D3D9Q35208258-78864C08-7E99-4F81-819F-A459573462F7Q35237788-1EABE54B-DC76-43EC-AD71-AD7D6BE85AE4Q35237835-B31BB3F2-1709-450E-A3F4-A757F471C699Q35513197-7408E4D4-6CCE-4677-991E-24DFB8D08452Q35635277-BE3C9BA0-17EC-4BD9-A9DF-B5A76ADA96C3Q35779492-23B7A714-42F2-4D89-94BA-EC0FEDFA537BQ35785286-F9A9EC75-99F2-484B-AABD-938233EBFA6CQ35816739-97CD0C68-32FD-4AE1-B42E-C27D9B493D9EQ35857562-2F02FA06-2A51-461C-A6E1-C8D2C602D962Q35920295-5BFA4253-D829-4D56-AEA0-E823B6CF9751Q35994316-6A85AF54-9E59-4145-A2A3-B136220ADAB9
P2860
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE
description
1965 nî lūn-bûn
@nan
1965年の論文
@ja
1965年学术文章
@wuu
1965年学术文章
@zh-cn
1965年学术文章
@zh-hans
1965年学术文章
@zh-my
1965年学术文章
@zh-sg
1965年學術文章
@yue
1965年學術文章
@zh
1965年學術文章
@zh-hant
name
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE
@en
type
label
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE
@en
prefLabel
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE
@en
P2860
P356
P1476
A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE
@en
P2093
PULVERTAFT JV
P2860
P304
P356
10.1136/JCP.18.3.261
P407
P577
1965-05-01T00:00:00Z